Show simple item record

AuthorJebara, Tesnime
AuthorCunningham, Scott
AuthorMacLure, Katie
AuthorPallivalapila, Abdulrouf
AuthorAwaisu, Ahmed
AuthorAl Hail, Moza
AuthorStewart, Derek
Available date2020-03-12T11:06:23Z
Publication Date2019-06-01
Publication NameResearch in Social and Administrative Pharmacyen_US
Identifierhttp://dx.doi.org/10.1016/j.sapharm.2019.06.009
CitationTesnime Jebara at. al. , Key stakeholders’ views on the potential implementation of pharmacist prescribing: A qualitative investigation, Research in Social and Administrative Pharmacy Volume 16, Issue 3, March 2020, Pages 405-414
URIhttp://hdl.handle.net/10576/13281
AbstractAn accumulation of international evidence demonstrates that pharmacist prescribing is effective, safe and well-accepted. While there is potential for such development in the Middle East, the majority of published studies are largely reported from Western countries and the perspectives of individuals in strategic positions of policy and practice in the Middle East were unknown. To explore the views of key stakeholders in Qatar regarding the potential development and implementation of pharmacist prescribing. Qualitative, face-to-face semi-structured interviews were conducted with stakeholders in strategic positions of policy influence (i.e. medical, pharmacy and nursing department directors, health-related academics, patient safety and quality directors, professional regulators). Stakeholders were recruited via purposive and snowball sampling. The interview schedule was constructed from an extensive literature review and grounded in the Consolidated Framework for Implementation Research (CFIR) to ensure comprehensive exploration of potential facilitators and barriers. Interviews were conducted from April to August 2017, digitally recorded, transcribed, and independently analysed by two researchers using CFIR as a coding framework. Thirty-seven interviews were conducted with directors of medicine (n = 5), pharmacy (n = 6) and nursing (n = 5), healthcare policy developers (n = 6), healthcare academics (n = 9), and patient safety advocates (n = 6). Interviewees were aware of pharmacist prescribing models internationally and generally supported development and implementation in Qatar due to perceived benefits of improved patient care, professional development and enhanced team working. While there were more facilitators than barriers, it was clear that there was a requirement to systematically plan the development and implementation of pharmacist prescribing, with reference to all five CFIR domains. The need for further training, demonstration of pharmacists' prescribing competence, and extensive engagement of stakeholders were considered crucial. There is potential for pharmacist prescribing to be developed and implemented in Qatar. Further research is warranted to define the models of prescribing suitable for Qatar, and to highlight issues of education, training and accreditation.
Languageen
PublisherElsevier
SubjectClinical pharmacy
SubjectImplementation
SubjectPharmacist
SubjectPrescribing
SubjectQatar
TitleKey stakeholders' views on the potential implementation of pharmacist prescribing: A qualitative investigation.
TypeArticle
Pagination405-414
Issue Number3
Volume Number16


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record